Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
World Journal of Emergency Surgery
Published in: World Journal of Emergency Surgery 1/2014

Open Access 01-12-2014 | Review

World Society of Emergency Surgery (WSES) guidelines for management of skin and soft tissue infections

Authors: Massimo Sartelli, Mark A Malangoni, Addison K May, Pierluigi Viale, Lillian S Kao, Fausto Catena, Luca Ansaloni, Ernest E Moore, Fred A Moore, Andrew B Peitzman, Raul Coimbra, Ari Leppaniemi, Yoram Kluger, Walter Biffl, Kaoru Koike, Massimo Girardis, Carlos A Ordonez, Mario Tavola, Miguel Cainzos, Salomone Di Saverio, Gustavo P Fraga, Igor Gerych, Michael D Kelly, Korhan Taviloglu, Imtiaz Wani, Sanjay Marwah, Miklosh Bala, Wagih Ghnnam, Nissar Shaikh, Osvaldo Chiara, Mario Paulo Faro Jr, Gerson Alves Pereira Jr, Carlos Augusto Gomes, Federico Coccolini, Cristian Tranà, Davide Corbella, Pietro Brambillasca, Yunfeng Cui, Helmut A Segovia Lohse, Vladimir Khokha, Kenneth YY Kok, Suk-Kyung Hong, Kuo-Ching Yuan

Published in: World Journal of Emergency Surgery | Issue 1/2014

Login to get access

Abstract

Skin and soft tissue infections (SSTIs) encompass a variety of pathological conditions ranging from simple superficial infections to severe necrotizing soft tissue infections. Necrotizing soft tissue infections (NSTIs) are potentially life-threatening infections of any layer of the soft tissue compartment associated with widespread necrosis and systemic toxicity. Successful management of NSTIs involves prompt recognition, timely surgical debridement or drainage, resuscitation and appropriate antibiotic therapy. A worldwide international panel of experts developed evidence-based guidelines for management of soft tissue infections. The multifaceted nature of these infections has led to a collaboration among surgeons, intensive care and infectious diseases specialists, who have shared these guidelines, implementing clinical practice recommendations.
Literature
1.
May AK: Skin and soft tissue infections. Surg Clin North Am. 2009, 89 (2): 403-420.PubMed
2.
Ustin JS, Malangoni MA: Necrotizing soft-tissue infections. Crit Care Med. 2011, 39 (9): 2156-2162.PubMed
3.
Guyatt G, Gutterman D, Baumann MH, Addrizzo-Harris D, Hylek EM, Phillips B, Raskob G, Lewis SZ, Schunemann H: Grading strength of recommendations and quality of evidence in clinical guidelines: Report from an American College of Chest Physicians task force. Chest. 2006, 129: 174-181.PubMed
4.
Brozek JL, Akl EA, Jaeschke R, Lang DM, Bossuyt P, Glasziou P, Helfand M, Ueffing E, Alonso-Coello P, Meerpohl J, Phillips B, Horvath AR, Bousquet J, Guyatt GH, Schunemann HJ: Grading quality of evidence and strength of recommendations in clinical practice guidelines: Part 2 of 3. The GRADE approach to grading quality of evidence about diagnostic tests and strategies. Allergy. 2009, 64: 1109-1116.PubMed
5.
Merlino JI, Malangoni MA: Complicated skin and soft-tissue infections: diagnostic approach and empiric treatment options. Cleve Clin J Med. 2007, 74 (Suppl 4): S21-8.PubMed
6.
Napolitano LM: Severe soft tissue infections. Infect Dis Clin North Am. 2009, 23: 571-591.PubMed
7.
Stevens DL, Bisno AL, Chambers HF, Everett ED, Dellinger P, Goldstein EJ, Gorbach SL, Hirschmann JV, Kaplan EL, Montoya JG, Wade JC, Infectious Diseases Society of America: Practice guidelines for the diagnosis and management of skin and soft-tissue infections. Clin Infect Dis. 2005, 41: 1373-406.PubMed
8.
Eron LJ, Lipsky BA, Low DE, Nathwani D, Tice AD, Volturo GA: Expert panel on managing skin and soft tissue infections. Managing skin and soft tissue infections: expert panel recommendations on key decision points. J Antimicrob Chemother. 2003, 52 (Suppl 1): i3-17.PubMed
9.
May AK, Stafford RE, Bulger EM, Heffernan D, Guillamondegui O, Bochicchio G, Eachempati SR: Surgical Infection Society. Surgical Infection Society. Treatment of complicated skin and soft tissue infections. Surg Infect (Larchmt). 2009, 10: 467-499.
10.
Lewis RT: Soft tissue infections. World J Surg. 1998, 22 (2): 146-151.PubMed
11.
Howell GM, Rosengart MR: Necrotizing soft tissue infections. Surg Infect (Larchmt). 2011, 12 (3): 185-190.
12.
Phan HH, Cocanour CS: Necrotizing soft tissue infections in the intensive care unit. Crit Care Med. 2010, 38 (9 Suppl): S460-8.PubMed
13.
Klevens RM, Edwards JR, Richards CL, Horan TC, Gaynes RP, Pollock DA, Cardo DM: Estimating health care–associated infections and deaths in U.S. hospitals. Public Health Rep. 2002, 122: 160-167.
14.
Kujath P, Kujath C: Complicated skin, skin structure and soft tissue infections - are we threatened by multi-resistant pathogens?. Eur J Med Res. 2010, 15 (12): 544-553.PubMedCentralPubMed
15.
Wheadle WG: Risk factors for surgical site infection. Surg Infect (Larchmt). 2006, 7 (Suppl 1): S7-11.
16.
Nelson RL, Glenny AM, Song F: Antimicrobial prophylaxis for colorectal surgery. Cochrane Database Syst Rev. 2009, 21 (1): CD001181.
17.
Bratzler DW, Dellinger EP, Olsen KM, Perl TM, Auwaerter PG, Bolon MK, Fish DN, Napolitano LM, Sawyer RG, Slain D, Steinberg JP, Weinstein RA: Clinical practice guidelines for antimicrobial prophylaxis in surgery. Surg Infect (Larchmt). 2013, 14: 73-156.
18.
Eriksson B, Jorup-Ronstrom C, Karkkonen K, Sjoblom AC, Holm SE: Erysipelas: clinical and bacteriologic spectrum and serological aspects. Clin Infect Dis. 1996, 23: 1091-1098.PubMed
19.
Morris AD: Cellulitis and erysipelas. Clin Evid (Online). 2008, 2: 2008-doi:pii: 1708
20.
Llera JL, Levy RC: Treatment of cutaneous abscess: a double-blind clinical study. Ann Emerg Med. 1985, 14: 15-19.PubMed
21.
Macfie J, Harvey J: The treatment of acute superficial abscesses: a prospective clinical trial. Br J Surg. 1977, 64: 264-266.PubMed
22.
Binswanger IA, Kral AH, Bluthenthal RN, Rybold DJ, Edlin BR: High prevalence of abscesses and cellulitis among community-recruited injection drug users in San Francisco. Clin Infect Dis. 2000, 30: 579-581.PubMed
23.
Lloyd-Smith E, Kerr T, Hogg RS, Li K, Montaner JS, Wood E: Prevalence and correlates of abscesses among a cohort of injection drug users. Harm Reduct J. 2005, 2: 24.PubMedCentralPubMed
24.
Pollini RA, Gallardo M, Hasan S, Minuto J, Lozada R, Vera A, Zúñiga ML, Strathdee SA: High prevalence of abscesses and self-treatment among injection drug users in Tijuana, Mexico. Int J Infect Dis. 2010, 14 (Suppl 3): e117-22.PubMed
25.
Khalil PN, Huber-Wagner S, Altheim S, Bürklein D, Siebeck M, Hallfeldt K, Mutschler W, Kanz GG: Diagnostic and treatment options for skin and soft tissue abscesses in injecting drug users with consideration of the natural history and concomitant risk factors. Eur J Med Res. 2008, 13 (9): 415-424.PubMed
26.
Brett MM, Hood J, Brazier JS, Duerden BI, Hahné SJ: Soft tissue infections caused by spore-forming bacteria in injecting drug users in the United Kingdom. Epidemiol Infect. 2005, 133 (4): 575-582.PubMedCentralPubMed
27.
Spijkerman IJ, van Ameijden EJ, Mientjes GH, Coutinho RA, van den Hoek A: Human immunodeficiency virus infection and other risk factors for skin abscesses and endocarditis among injection drug users. J Clin Epidemiol. 1996, 49: 1149-1154.PubMed
28.
Gilchrist J, Sacks JJ, White D, Kresnow MJ: Dog bites: still a problem?. Inj Prev. 2008, 14 (5): 296-301.PubMed
29.
Goldstein EJC: Bite wounds and infections. Clin Infect Dis. 1992, 14: 633.PubMed
30.
Weber DJ, Hansen AR: Infections resulting from animal bites. Infect Dis Clin North Am. 1991, 5: 663.PubMed
31.
Hackett SP, Stevens DL: Streptococcal toxic shock syndrome: synthesis of tumor necrosis factor and interleukin-1 by monocytes stimulated with pyrogenic exotoxin A and streptolysin O. J Infect Dis. 1992, 165: 879-885.PubMed
32.
Lancerotto L, Tocco I, Salmaso R, Vindigni V, Bassetto F: Necrotizing fasciitis: classification, diagnosis, and management. J Trauma Acute Care Surg. 2012, 72: 560-6.PubMed
33.
Cainzos M, Gonzalez-Rodriguez FJ: Necrotizing soft tissue infections. Curr Opin Crit Care. 2007, 13: 433-439.PubMed
34.
Naqvi GA, Malik SA, Jan W: Necrotizing fasciitis of the lower extremity: a case report and current concept of diagnosis and management. Scand J Trauma Resusc Emerg Med. 2009, 17: 28.PubMedCentralPubMed
35.
Salcido RS: Necrotizing fasciitis: reviewing the causes and treatment strategies. Adv Skin Wound Care. 2007, 20: 288-293.PubMed
36.
Anaya DA, McMahon K, Nathens AB, Sullivan SR, Foy H, Bulger E: Predictors of mortality and limb loss in necrotizing soft tissue infections. Arch Surg. 2005, 140 (2): 151-157.PubMed
37.
Taviloglu K, Cabioglu N, Cagatay A, Yanar H, Ertekin C, Baspinar I, Ozsut H, Guloglu R: Idiopathic necrotizing fasciitis: risk factors and strategies for management. Am Surg. 2005, 71 (4): 315-320.PubMed
38.
el Benjelloun B1, Souiki T, Yakla N, Ousadden A, Mazaz K, Louchi A, Kanjaa N, Taleb KA: Fournier’s gangrene: our experience with 50 patients and analysis of factors affecting mortality. World J Emerg Surg. 2013, 8: 13.PubMedCentralPubMed
39.
Ghnnam WM: Fournier’s gangrene in Mansoura Egypt: A review of 74 cases. J Postgrad Med. 2008, 54: 106-109.PubMed
40.
Ynar H, Taviloglu K, Ertekin C, Guloglu R, Zorba U, Cabioglu N, Baspinar I: Fournier’s gangrene: risk factors and strategies for management. World J Surg. 2006, 30: 1750-1754.
41.
McCloud JM, Doucas H, Scott AD, Jameson JS: Delayed presentation of life-threatening perineal sepsis following stapled haemorrhoidectomy: a case report. Ann R Coll Surg Engl. 2007, 89 (3): 301-302.PubMedCentralPubMed
42.
Laor E, Palmer LS, Tolia BM, Reid RE, Winter HI: Outcome prediction in patients with Fournier's gangrene. J Urol. 1995, 154 (1): 89-92.PubMed
43.
44.
Dryden MS: Complicated skin and soft tissue infection. J Antimicrob Chemother. 2010, 65 (Suppl 3): iii35-44.PubMed
45.
46.
Moet GJ, Jones RN, Biedenbach DJ, Stilwell MG, Fritsche TR: Contemporary causes of skin and soft tissue infections in North America, Latin America, and Europe: report from the SENTRY Antimicrobial Surveillance Program (1998–2004). Diagn Microbiol Infect Dis. 2007, 57: 7-13.PubMed
47.
Nathwani D, Morgan M, Masterton RG, Dryden M, Cookson BD, French G, Lewis D, British Society for Antimicrobial Chemotherapy Working Party on Community-onset MRSA Infections: Guidelines for UK practice for the diagnosis and management of methicillin-resistant Staphylococcus aureus (MRSA) infections presenting in the community. J Antimicrob Chemother. 2008, 61 (5): 976-994.PubMed
48.
Vandenesch F, Naimi T, Enright MC, Lina G, Nimmo GR, Heffernan H, Liassine N, Bes M, Greenland T, Reverdy ME, Etienne J: Community-acquired methicillin resistant Staphylococcus aureus carrying Panton–Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis. 2003, 9: 978-984.PubMedCentralPubMed
49.
Genestier AL, Michallet MC, Prévost G, Bellot G, Chalabreysse L, Peyrol S, Thivolet F, Etienne J, Lina G, Vallette FM, Vandenesch F, Genestier L: Staphylococcus aureus Panton–Valentine leukocidin directly targets mitochondria and induces Bax-independent apoptosis of human neutrophils. J Clin Invest. 2005, 115: 3117-3127.PubMedCentralPubMed
50.
Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJ, Kaplan SL, Karchmer AW, Levine DP, Murray BE, Rybak JM, Talan DA, Chambers HF, Infectious Diseases Society of America: Clinical practice guidelines by the infectious diseases society of America for the treatment of Methicillin-resistant Staphylococcus Aureus infections in adults and children. Clin Infect Dis. 2011, 52 (3): e18-55.PubMed
51.
Awad SS, Elhabash SI, Lee L, Farrow B, Berger DH: Increasing incidence of methicillin-resistant Staphylococcus aureus skin and soft-tissue infections: reconsideration of empiric antimicrobial therapy. Am J Surg. 2007, 194: 606-610.PubMed
52.
Moise-Broder PA, Sakoulas G, Eliopoulos GM, Schentag JJ, Forrest A, Moellering RC: Accessory gene regulator group II polymorphism in methicillin-resistant Staphylococcus aureus is predictive of failure of vancomycin therapy. Clin Infect Dis. 2004, 38: 1700-1705.PubMed
53.
Falagas ME, Siempos II, Vardakas KZ: Linezolid versus glycopeptide or β-lactam for treatment of Gram-positive bacterial infections: meta-analysis of randomised controlled trials. Lancet Infect Dis. 2008, 8: 53-66.PubMed
54.
Itani KM, Dryden MS, Bhattacharyya H, Kunkel MJ, Baruch AM, Weigelt JA: Efficacy and safety of linezolid versus vancomycin for the treatment of complicated skin and soft-tissue infections proven to be due to methicillin-resistant Staphylococcus aureus. Am J Surg. 2010, 199: 804-816.PubMed
55.
Yue J, Dong BR, Yang M, Chen X, Wu T, Liu GJ: Linezolid versus vancomycin for skin and soft tissue infections. Cochrane Database Syst Rev. 2013, 7: CD008056.PubMed
56.
Ellis-Grosse EJ, Babinchak T, Dartois N, Rose G, Loh E, Tigecycline 300 cSSSI Study Group: The efficacy and safety of tigecycline in the treatment of skin and skin-structure infections: results of 2 double-blind phase 3 comparison studies with vancomycin-aztreonam. Clin Infect Dis. 2005, 41: S341-53.PubMed
57.
Stein GE, Smith CL, Missavage A, Saunders JP, Nicolau DP, Battjes SM, Kepros JP: Tigecycline penetration into skin and soft tissue. Surg Infect (Larchmt). 2011, 12 (6): 465-467.
58.
Seaton RA: Daptomycin: rationale and role in the management of skin and soft tissue infections. J Antimicrob Chemother. 2008, 62 (Suppl 3): iii15-23.PubMed
59.
Bliziotis IA, Plessa E, Peppas G, Falagas ME: Daptomycin versus other antimicrobial agents for the treatment of skin and soft tissue infections: a meta-analysis. Ann Pharmacother. 2010, 44 (1): 97-106.PubMed
60.
Ruhe JJ, Smith N, Bradsher RW, Menon A: Community-onset methicillin-resistant Staphylococcus aureus skin and soft tissue infections: impact of antimicrobial therapy on outcome. Clin Infect Dis. 2007, 44: 777-784.PubMed
61.
Berger A, Oster G, Edelsberg J, Huang X, Weber DJ: Initial treatment failure in patients with complicated skin and skin structure infections. Surg Infect (Larchmt). 2013, 14 (3): 304-312.
62.
Marshall JC, Maier RV, Jimenez M, Dellinger EP: Source control in the management of severe sepsis and septic shock: an evidence-based review. Crit Care Med. 2004, 32 (Suppl 11): S513-26.PubMed
63.
Keung EZ, Liu X, Nuzhad A, Adams C, Ashley SW, Askari R: Immunocompromised status in patients with necrotizing soft-tissue infection. JAMA Surg. 2013, 148 (5): 419-426.PubMed
64.
May AK, Stafford RE, Bulger EM, Heffernan D, Guillamondegui O, Bochicchio G, Eachempati SR, Surgical Infection Society: Treatment of complicated skin and soft tissue infections. Surg Infect (Larchmt). 2009, 10 (5): 467-469.
65.
Swartz MN: Clinical practice: Cellulitis. N Engl J Med. 2004, 350: 904-912.PubMed
66.
Stevens DL, Gibbons AE, Bergstrom R, Winn V: The Eagle effect revisited: Efficacy of clindamycin, erythromycin, and penicillin in the treatment of streptococcal myositis. J Infect Dis. 1988, 158: 23-28.PubMed
67.
Rajan S: Skin and soft-tissue infections: classifying and treating a spectrum. Cleve Clin J Med. 2012, 79 (1): 57-66.PubMed
68.
Newell PM, Norden CW: Value of needle aspiration in bacteriologic diagnosis of cellulitis in adults. J Clin Microbiol. 1988, 26: 401-404.PubMedCentralPubMed
69.
Brook I, Frazier EH: Aerobic and anaerobic bacteriology of wounds and cutaneous abscesses. Arch Surg. 1990, 125: 1445-1451.PubMed
70.
Wong CH, Khin LW, Heng KS, Tan KC, Low CO: The LRINEC (Laboratory Risk Indicator for Necrotizing Fasciitis) score: a tool for distinguishing necrotizing fasciitis from other soft tissue infections. Crit Care Med. 2004, 32: 1535.PubMed
71.
Malghem J, Lecouvet FE, Omoumi P, Maldague BE, Vande Berg BC: Necrotizing fasciitis: contribution and limitations of diagnostic imaging. Joint Bone Spine. 2013, 80: 146-54.PubMed
72.
Angoules AG, Kontakis G, Drakoulakis E, Vrentzos G, Granick MS, Giannoudis PV: Necrotising fasciitis of upper and lower limb: a systematic review. Injury. 2007, 38 (Suppl 5): S19-26.PubMed
73.
Walshaw CF, Deans H: CT findings in necrotising fasciitis—a report of four cases. Clin Radiol. 1996, 51 (6): 429-432.PubMed
74.
Zacharias N, Velmahos GC, Salama A, Alam HB, de Moya M, King DR, Novelline RA: Diagnosis of necrotizing soft tissue infections by computed tomography. Arch Surg. 2010, 145 (5): 452-455.PubMed
75.
Kim KT, Kim YJ, Won Lee J, Kim YJ, Park SW, Lim MK, Suh CH: Can necrotizing infectious fasciitis be differentiated from nonnecrotizing infectious fasciitis with MR imaging?. Radiology. 2011, 259 (3): 816-824.PubMed
76.
Schmid MR, Kossmann T, Duewell S: Differentiation of necrotizing fasciitis and cellulitis using MR imaging. Am J Roentgenol. 1998, 170 (3): 615-620.
77.
Yen ZS, Wang HP, Ma HM, Chen SC, Chen WJ: Ultrasonographic screening of clinically-suspected necrotizing fasciitis. Acad Emerg Med. 2002, 9 (12): 1448-1451.PubMed
78.
Majeski J, Majeski E: Necrotizing fasciitis: improved survival with early recognition by tissue biopsy and aggressive surgical treatment. South Med J. 1997, 90: 1065-1068.PubMed
79.
Stamenkovic I, Lew PD: Early recognition of potentially fatal necrotizing fasciitis: the use of frozen-section biopsy. N Engl J Med. 1984, 310: 1689-1693.PubMed
80.
Anaya DA, Dellinger EP: Necrotizing soft-tissue infection: diagnosis and management. Clin Infect Dis. 2007, 44 (5): 705-710.PubMed
81.
Andreasen TJ, Green SD, Childers BJ: Massive infectious soft-tissue injury: diagnosis and management of necrotizing fasciitis and purpura fulminans. Plast Reconstr Surg. 2001, 107 (4): 1025-1035.PubMed
82.
McHenry CR, Piotrowski JJ, Petrinic D, Malangoni MA: Determinants of mortality for necrotizing soft tissue infections. Ann Surg. 1995, 221: 558.PubMedCentralPubMed
83.
Bronder CS, Cowey A, Hill J: Delayed stoma formation in Fournier’s gangrene. Colorectal Dis. 2004, 6: 518-520.PubMed
84.
Mallikarjuna MN, Vijayakumar A, Patil VS, Shivswamy BS: Fournier’s Gangrene: Current Practices. ISRN Surg. 2012, 2012: 942437.PubMedCentralPubMed
85.
Estrada O, Martinez I, Del Bas M, Salvans S, Hidalgo LA: Rectal diversion without colostomy in Fournier’s gangrene. Tech Coloproctol. 2009, 13 (2): 157-159.PubMed
86.
Bilton BD, Zibari GB, McMillan RW, Aultman DF, Dunn G, McDonald JC: Aggressive surgical management of necrotizing fasciitis serves to decrease mortality: a retrospective study. Am Surg. 1998, 64 (5): 397-400.PubMed
87.
Huang WS, Hsieh SC, Hsieh CS, Schoung JY, Huang T: Use to manage limb wounds in patients suffering from acute necrotizing fasciitis. Asian J Surg. 2006, 29 (3): 135-139.PubMed
88.
Silberstein J, Grabowski J, Parsons JK: Use of a vacuum-assisted device for Fournier’s gangrene: a new paradigm. Rev Urol. 2008, 10 (1): 76-80.PubMedCentralPubMed
89.
Ozturk E, Ozquc H, Yilmazlar T: The use of vacuum-assisted closure therapy in the management of Fournier’s gangrene. Am J Surg. 2009, 197: 660-665.PubMed
90.
George ME, Rueth NM, Skarda DE, Chipman JG, Quickel RR, Beilman GJ: Hyperbaricoxygen does not improve outcome in patients with necrotizing soft tissue infection. Surg Infect (Larchmt). 2009, 10 (1): 21-28.
91.
Soh CR, Pietrobon R, Freiberger JJ, Chew ST, Rajgor D, Gandhi M, Shah J, Moon RE: Hyperbaric oxygen therapy in necrotising soft tissue infections: a study of patients in the United States nationwide Inpatient Sample. Intensive Care Med. 2012, 38 (7): 1143-1151.PubMed
92.
Eskes A, Vermeulen H, Lucas C, Ubbink DT: Hyperbaric oxygen therapy for treating acute surgical and traumatic wounds. Cochrane Database Syst Rev. 2013, 12: CD008059.PubMed
93.
Hassan Z, Mullins RF, Friedman BC, Shaver JR, Brandigi C, Alam B, Mian MA: Treating necrotizing fasciitis with or without hyperbaric oxygen Therapy. Undersea Hyperb Med. 2010, 37 (2): 115-123.PubMed
94.
Wong CH, Chang HC, Pasupathy S, Khin LW, Tan JL, Low CO: Necrotizing fasciitis: linical presentation, microbiology, and determinants of mortality. J Bone Joint Surg Am. 2003, 85 (8): 1454-1460.PubMed
95.
Elliot D, Kufera JA, Myers RA: The microbiology of necrotizing soft tissue infections. Am J Surg. 2000, 179 (5): 361-366.
96.
97.
Miller LG, Perdreau-Remington F, Rieg G, Mehdi S, Perlroth J, Bayer AS, Tang AW, Phung TO, Spellberg B: Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles. N Engl J Med. 2005, 352 (14): 1445-1453.PubMed
98.
King MD, Humphrey BJ, Wang YF, Kourbatova EV, Ray SM, Blumberg HM: Emergence of community-acquired methicillin-resistant Staphylococcus aureus USA 300 clone as the predominant cause of skin and soft-tissue infections. Ann Intern Med. 2006, 144 (5): 309-317.PubMed
99.
Coyle EA, Cha R, Rybak MJ: Influences of linezolid, penicillin, and clindamycin, alone and in combination, on streptococcal pyrogenic exotoxin a release. Antimicrob Agents Chemother. 2003, 47 (5): 1752-1755.PubMedCentralPubMed
100.
Stevens DL, Ma Y, Salmi DB, McIndoo E, Wallace RJ, Bryant AE: Impact of antibiotics on expression of virulence-associated exotoxin genes in methicillin-sensitive and methicillin-resistant Staphylococcus aureus. J Infect Dis. 2007, 195 (2): 202-211.PubMed
101.
Smeets L, Bous A, Heymans O: Necrotizing fasciitis: case report and review of literature. Acta Chir Belg. 2007, 107 (1): 29-36.PubMed
102.
Angus DC, van der Poll T: Severe sepsis and septic shock. N Engl J Med. 2013, 369 (9): 840-851.PubMed
103.
Dellinger RP, Mitchell Levy M, Andrew R, Djillali A, Sponsoring organizations: American Association of Critical-Care Nurses, et al: Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Intensive Care Med. 2013, 39: 165-228.PubMed
104.
Aduen J, Bernstein WK, Khastgir T, Miller J, Kerzner R, Bhatiani A, Lustgarten J, Bassin AS, Davison L, Chernow B: The use and clinical importance of a substrate-specific electrode for rapid determination of blood lactate concentrations. JAMA. 1994, 272: 1678-1685.PubMed
105.
Mikkelsen ME, Miltiades AN, Gaieski DF, Goyal M, Fuchs BD, Shah CV, Bellamy SL, Christie JD: Serum lactate is associated with mortality in severe sepsis independent of organ failure and shock. Crit Care Med. 2009, 37: 1670-1677.PubMed
106.
Trzeciak S, Dellinger RP, Chansky ME, Arnold RC, Schorr C, Milcarek B, Hollenberg SM, Parrillo JE: Serum lactate as a predictor of mortality in patients with infection. Intensive Care Med. 2007, 33: 970-977.PubMed
107.
Shapiro NI, Howell MD, Talmor D, Nathanson LA, Lisbon A, Wolfe RE, Weiss JW: Serum lactate as a predictor of mortality in emergency department patients with infection. Ann Emerg Med. 2005, 45: 524-528.PubMed
108.
109.
Nguyen HB, Rivers EP, Knoblich BP, Jacobsen G, Muzzin A, Ressler JA, Tomlanovich MC: Early lactate clearance is associated with improved outcome in severe sepsis and septic shock. Crit Care Med. 2004, 32: 1637-1642.PubMed
110.
Perel P, Roberts I: Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev. 2011, 3: CD000567.PubMed
111.
Darenberg J, Ihendyane N, Sjölin J, Aufwerber E, Haidl S, Follin P, Andersson J, Norrby-Teglund A, StreptIg Study Group: Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: a European randomized, double-blind, placebo-controlled trial. Clin Infect Dis. 2003, 37 (3): 333-340.PubMed
112.
Schrage B, Duan G, Yang LP, Fraser JD, Proft T: Different preparations of intravenous immunoglobulin vary in their efficacy to neutralize streptococcal superantigens: implications for treatment of streptococcal toxic shock syndrome. Clin Infect Dis. 2006, 43: 743-746.PubMed
113.
Childers BJ, Potyondy LD, Nachreiner R, Rogers FR, Childers ER, Oberg KC, Hendricks DL, Hardesty RA: Necrotizing fasciitis: a fourteen-year retrospective study of 163 consecutive patients. Am Surg. 2002, 68 (2): 109-116.PubMed
114.
Uehara M, Plank LD, Hill GL: Components of energy expenditure in patients with severe sepsis and major trauma: a basis for clinical care. Crit Care Med. 1999, 27: 1295-1302.PubMed
115.
Krishnan JA, Parce PB, Martinez A, Diette GB, Brower RG: Caloric intake in medical ICU patients: consistency of care with guidelines and relationship to clinical outcomes. Chest. 2003, 124: 297-305.PubMed
116.
Villet S, Chiolero RL, Bollmann MD, Revelly JP, Cayeux RNMC, Delarue J, Berger MM: Negative impact of hypocaloric feeding and energy balance on clinical outcome in ICU patients. Clin Nutr. 2005, 24: 502-509.PubMed
Metadata
Title
World Society of Emergency Surgery (WSES) guidelines for management of skin and soft tissue infections
Authors
Massimo Sartelli
Mark A Malangoni
Addison K May
Pierluigi Viale
Lillian S Kao
Fausto Catena
Luca Ansaloni
Ernest E Moore
Fred A Moore
Andrew B Peitzman
Raul Coimbra
Ari Leppaniemi
Yoram Kluger
Walter Biffl
Kaoru Koike
Massimo Girardis
Carlos A Ordonez
Mario Tavola
Miguel Cainzos
Salomone Di Saverio
Gustavo P Fraga
Igor Gerych
Michael D Kelly
Korhan Taviloglu
Imtiaz Wani
Sanjay Marwah
Miklosh Bala
Wagih Ghnnam
Nissar Shaikh
Osvaldo Chiara
Mario Paulo Faro Jr
Gerson Alves Pereira Jr
Carlos Augusto Gomes
Federico Coccolini
Cristian Tranà
Davide Corbella
Pietro Brambillasca
Yunfeng Cui
Helmut A Segovia Lohse
Vladimir Khokha
Kenneth YY Kok
Suk-Kyung Hong
Kuo-Ching Yuan
Publication date
01-12-2014
Publisher
BioMed Central
Published in
World Journal of Emergency Surgery / Issue 1/2014
Electronic ISSN: 1749-7922
DOI
https://doi.org/10.1186/1749-7922-9-57

Other articles of this Issue 1/2014

World Journal of Emergency Surgery 1/2014 Go to the issue

Research article

Extended negative pressure wound therapy-assisted dermatotraction for the closure of large open fasciotomy wounds in necrotizing fasciitis patients

Commentary

Emergency surgeon: “ last of the mohicans” 2014-2016 editorial policy WSES- WJES: position papers, guidelines, courses, books and original research; from WJES impact factor to WSES congress impact factor

Review

Strangulated or incarcerated spontaneous lumbar hernia as exceptional cause of intestinal obstruction: case report and review of the literature

Review

Toothpick ingestion complicated by cecal perforation: case report and literature review

Review

Blunt cerebrovascular injury in rugby and other contact sports: case report and review of the literature

Research article

Patient delay is the main cause of treatment delay in acute limb ischemia: an investigation of pre- and in-hospital time delay